Although the proportion of patients showing a response to treatment based on a hybrid SLEDAI (hSLEDAI) measured at week 4 (primary endpoint) did not reach statistical significance, several secondary endpoints were attained (BILAG-2004; Cutaneous Lupus Erythematosus Disease Area and Severity Index [CLASI]-Activity; tender and swollen joint count; PGA).
← all excerpts
A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus.
1
—
—